Abstract:Chenglin Ye, 1, &ast Sizhe Zhu, 2, &ast Jingping Yuan, 1 Xiuxue Yuan 3 1 Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China; 2 Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, People's Republic of China; 3 Medical College of Wuhan University of Science and Technology, Wuhan, Hubei, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jingping Yuan; Xiuxue Yuan, Email ; Purpose: Crohn's disease (CD) represents a multifaceted inflammatory gastrointestinal condition, with a profound significance placed on unraveling its molecular pathways to enhance both diagnostic capabilities and therapeutic interventions. This study focused on identifying a robust macrophage-related signatures (MacroSig) for diagnosing CD, emphasizing the role of FPR1 in macrophage polarization and its implications in CD. Patients and Methods: Expression profiles from intestinal biopsies and macrophages of 1804 CD patients were retrieved from the Gene Expression Omnibus (GEO). Utilizing CIBERSORTx, differential expression analysis, and weighted correlation network analysis to to identify macrophage-related genes (MRGs). By unsupervised clustering, distinct clusters of CD were identified. Potential biomarkers were identified via using four machine learning algorithms, leading to the establishment of MacroSig which combines insights from 12 machine learning algorithms. Furthermore, the expression of FPR1 was verified in intestinal biopsies of CD patients and two murine experimental colitis models. Finally, we further explored the role of FPR1 in macrophage polarization through single-cell analysis as well as through the study of RAW264.7 cells and peritoneal macrophages. Results: Two distinct clusters with differential levels of macrophage infiltration and inflammation were identified. The MacroSig, which included FPR1 and LILRB2, exhibited high diagnostic accuracy and outperformed existing biomarkers and signatures. Clinical analysis demonstrated a strong correlation of FPR1 with disease activity, endoscopic inflammation status, and response to infliximab treatment. The expression levels of FPR1 were validated in our CD cohort by immunohistochemistry and confirmed in two colitis mouse models. Single-cell analysis indicated that FPR1 is predominantly expressed in macrophages and monocytes. In vitro studies demonstrated that FPR1 was upregulated in M1 macrophages, and its activation promoted M1 polarization. Conclusion: We developed a promising diagnostic signature for CD, and targeting FPR1 to modulate macrophage polarization may represent a novel therapeutic strategy. Keywords: Crohn's disease, macrophage, diagnostic signature, FPR1, machine learning Crohn's disease (CD) is a subtype of inflammatory bowel disease (IBD) that affects the gastrointestinal tract. 1 The disease is characterized by periods of remission and relapse, with symptoms ranging from abdominal pain and diarrhea to severe complications such as fistulas and intestinal obstruction. 2 Since the 20th century, the global incidence of CD has increased markedly, particularly in emerging industrialized nations within Asia, Africa, and South America. 3 This rise is attributed to changes in lifestyle, dietary habits, and increased exposure to environmental risk factors in these regions. 4 The pathogenesis of CD involves multiple factors, including genetic predisposition, environmental influences, and immune system dysregulation. 5 Dysfunction and hyperactivity in the immune response are key factors that contribute to uncontrolled inflammation, a defining feature of CD. 6 Consequently, addressing these factors is crucial in the treatment of CD. Macrophages play a pivotal role in maintaining intestinal immune homeostasis. 7,8 The transition of macrophages from protectors to aggressors, under the influence of environmental and genetic determinants, represents a crucial element of CD pathogenesis. 8 Macrophages present heterogeneity and are known for two main phenotypes: the pro-inflammatory M1 and the anti-inflammatory M2. M1 macrophages, stimulated by bacterial lipopolysaccharide (LPS), exacerbate inflammation through the production of cytokines like tumor necrosis factor alpha (TNF-α), interleukin (IL)-1β, IL-6, and IL-23. On the contrary, M2 macrophages, when activated by IL-4, boost tissue repair and resolution of inflammation by releasing anti-inflammatory cytokines like arginase 1 and IL-10. 9–12 In CD -Abstract Truncated-

Fecal bacteria from Crohn's disease patients more potently activated NOD-like receptors and Toll-like receptors in macrophages, in an IL-4-repressible fashion.

Preoperative embolization of arteriovenous malformations with polylene threads: techniques with wing microcatheter and pathologic results.

Role of gut microbiota in Crohn's disease pathogenesis: Insights from fecal microbiota transplantation in mouse model

Patients with no functional improvement after total knee arthroplasty show different kinematics

Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease.

Bacterial Characteristics of Intestinal Tissues from Patients with Crohn’s Disease

Identification of key taxa that favor intestinal colonization of Clostridium difficile in an adult Chinese population

Fecal microbiota transplantation alleviates experimental colitis through the Toll-like receptor 4 signaling pathway

Molecular-Phylogenetic Characterization of the Microbiota in Ulcerated and Non-Ulcerated Regions in the Patients with Crohn's Disease

FPR1, as a Potential Biomarker of Diagnosis and Infliximab Therapy Responses for Crohn's Disease, is Related to Disease Activity, Inflammation and Macrophage Polarization

Correlation between altered gut microbiota and elevated inflammation markers in patients with Crohn’s disease

Transplant of microbiota from Crohn's disease patients to germ-free mice results in colitis

[A case of surgically treated simultaneous bilateral squamous cell carcinoma of the lung].

Gut bacterial type III secretion systems aggravate colitis in mice and serve as biomarkers of Crohn's disease

Changes of the fungal microbiota in inflamed intestinal mucosa of the patients with Crohn's disease

Human Intestinal Macrophages Are Involved in the Pathology of Both Ulcerative Colitis and Crohn Disease

Influence of Crohn's disease related polymorphisms in innate immune function on ileal microbiome

Th1 Promotes M1 Polarization of Intestinal Macrophages to Regulate Colitis-Related Mucosal Barrier Damage.

P1194 Single-cell analysis reveals clonal expansions of pro-inflammatory tissue-resident memory Th17 cells in Crohn's disease

Fecal fungal microbiota alterations associated with clinical phenotypes in Crohn’s disease in southwest China

Macrophages Inability to Mediate Adherent-Invasive E. coli Replication is Linked to Autophagy in Crohn's Disease Patients